Business December 18, 2021
JPMorgan to pay $200 million to settle regulatory violations over its recordkeeping
JPMorgan agreed to pay a total of 200 million penalties to settle regulatory violations related to its widespread recordkeeping and…
Business December 18, 2021
JPMorgan agreed to pay a total of 200 million penalties to settle regulatory violations related to its widespread recordkeeping and…
By Marivic Cabural Summers
Investigates March 3, 2019
The U.S. Food and Drug Administration (FDA) warned CanaRx, a Canadian company, for selling “unapproved and misbranded” medicines from foreign…
By Catherine Davis